NO20012099L - Fremgangsmåte for fremstilling av 4-arylpiperidin-3- karbinoler og beslektede forbindelser - Google Patents
Fremgangsmåte for fremstilling av 4-arylpiperidin-3- karbinoler og beslektede forbindelserInfo
- Publication number
- NO20012099L NO20012099L NO20012099A NO20012099A NO20012099L NO 20012099 L NO20012099 L NO 20012099L NO 20012099 A NO20012099 A NO 20012099A NO 20012099 A NO20012099 A NO 20012099A NO 20012099 L NO20012099 L NO 20012099L
- Authority
- NO
- Norway
- Prior art keywords
- arylpiperidine
- carbinols
- preparation
- related compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10667398P | 1998-11-02 | 1998-11-02 | |
| PCT/IB1999/001762 WO2000026187A1 (en) | 1998-11-02 | 1999-11-01 | Process for producing 4-arylpiperidine-3-carbinols and related compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012099D0 NO20012099D0 (no) | 2001-04-27 |
| NO20012099L true NO20012099L (no) | 2001-07-02 |
Family
ID=22312658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012099A NO20012099L (no) | 1998-11-02 | 2001-04-27 | Fremgangsmåte for fremstilling av 4-arylpiperidin-3- karbinoler og beslektede forbindelser |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1124802A1 (no) |
| AU (1) | AU6360999A (no) |
| CZ (1) | CZ20011465A3 (no) |
| NO (1) | NO20012099L (no) |
| WO (1) | WO2000026187A1 (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE279393T1 (de) * | 1997-05-29 | 2004-10-15 | Smithkline Beecham Corp | Neues verfahren |
| WO2000037443A1 (en) * | 1998-12-22 | 2000-06-29 | Pentech Pharmaceuticals, Inc. | Process for preparing arylpiperidine carbinol intermediates and derivatives |
| US20010053862A1 (en) * | 1998-12-22 | 2001-12-20 | Bruce Ronsen | Process for preparing arylpiperidine carbinol intermediates and derivatives |
| EP1280775A1 (en) * | 2000-05-12 | 2003-02-05 | Synthon B.V. | TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS |
| ATE282594T1 (de) | 2001-01-04 | 2004-12-15 | Ferrer Int | Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin |
| ATE285408T1 (de) | 2001-10-22 | 2005-01-15 | Synthon Bv | Paroxetin-n-formyl-derivate |
| WO2007089193A1 (en) * | 2006-02-02 | 2007-08-09 | Astrazeneca Ab | A process for preparing 2-hydroxy-3- [5- (morpholin-4-ylmethyl)pyridin-2-yl] lh-indole-5-carbonitrile as a free base or salts thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI792076A (fi) * | 1978-07-05 | 1980-01-06 | Ciba Geigy Ag | Foerfarande foer framstaellning av nya fenylpiperidinderivat |
| DE3680184D1 (de) * | 1985-08-10 | 1991-08-14 | Beecham Group Plc | Verfahren zur herstellung von arylpiperidincarbinol. |
| US5258517A (en) * | 1992-08-06 | 1993-11-02 | Sepracor, Inc. | Method of preparing optically pure precursors of paroxetine |
| GB9526645D0 (en) * | 1995-12-28 | 1996-02-28 | Chiroscience Ltd | Stereoselective synthesis |
| JP3446468B2 (ja) * | 1996-04-15 | 2003-09-16 | 旭硝子株式会社 | ピペリジンカルビノール類の製造方法 |
| ATE279393T1 (de) * | 1997-05-29 | 2004-10-15 | Smithkline Beecham Corp | Neues verfahren |
-
1999
- 1999-11-01 CZ CZ20011465A patent/CZ20011465A3/cs unknown
- 1999-11-01 AU AU63609/99A patent/AU6360999A/en not_active Abandoned
- 1999-11-01 WO PCT/IB1999/001762 patent/WO2000026187A1/en not_active Application Discontinuation
- 1999-11-01 EP EP99951035A patent/EP1124802A1/en not_active Withdrawn
-
2001
- 2001-04-27 NO NO20012099A patent/NO20012099L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20012099D0 (no) | 2001-04-27 |
| EP1124802A1 (en) | 2001-08-22 |
| CZ20011465A3 (cs) | 2001-08-15 |
| AU6360999A (en) | 2000-05-22 |
| WO2000026187A1 (en) | 2000-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015547L (no) | Fremgangsmåte for hemisyntese av forbindelser og nye forbindelser | |
| NO975759D0 (no) | Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel | |
| NO20000227L (no) | Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmåte for dens fremstilling og dens anvendelse | |
| DK0985697T3 (da) | Oxiranderivater og fremgangsmåde til fremstilling deraf | |
| NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
| NO20003427L (no) | Lomasse og fremgangsmÕte for dens fremstilling | |
| NO20015542D0 (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| NO20004896D0 (no) | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav | |
| NO20003070D0 (no) | Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav | |
| NO972477D0 (no) | Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse | |
| NO991382L (no) | Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin | |
| HK1041827B (zh) | 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法 | |
| NO994505L (no) | Forbedret fremgangsmåte for fremstilling av tiazolidindioner og nye tiazolidindioner | |
| NO20012099L (no) | Fremgangsmåte for fremstilling av 4-arylpiperidin-3- karbinoler og beslektede forbindelser | |
| NO20003454D0 (no) | FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4- | |
| NO996432L (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
| NO993863D0 (no) | Forbindelser og fremgangsmåte for fremstilling av substituerte 4-fenyl-4-cyanocycloheksansyrer | |
| NO996467D0 (no) | Fremgangsmåte for fremstilling av tiazofurin og andre C- nukleosider | |
| NO971419L (no) | Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder | |
| NO20006383L (no) | Fremgangsmåte for behandling | |
| NO990185D0 (no) | FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter | |
| NO990018D0 (no) | Belegg og fremgangsmÕte for fremstilling derav | |
| NO20013044D0 (no) | Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater | |
| NO20012811D0 (no) | Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat | |
| NO20003077D0 (no) | FremgangsmÕte for fremstilling av klorbenzooksazolen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |